What the research found

A randomized 18-month trial of 294 middle-aged adults (mostly men) with metabolic risk factors compared three dietary approaches: standard healthy guidelines, Mediterranean diet with walnuts, and a "green Mediterranean" variant that added daily green tea and a blended shake made from Mankai (a cultivated duckweed high in protein and polyphenols). The study was conducted in a workplace setting where lunch was monitored, lending credibility to adherence tracking—a common weakness in nutrition research.

The green Mediterranean group showed the largest reductions in liver fat (median 38.9% versus 19.6% in the standard Mediterranean group), measured directly via MRI rather than inferred from blood tests. Fatty liver disease prevalence fell from 62% to 31.5% in the green group over 18 months. Brain imaging in participants over 50 showed less hippocampal shrinkage and ventricle expansion in the green group—markers associated with age-related neurodegeneration. Cardiometabolic measures also favored the green approach: waist circumference declined more, insulin resistance improved further, and inflammatory markers fell more steeply.

Notably, the two Mediterranean arms were matched for calories, so differences reflected food composition rather than overall energy intake. Greater improvement in liver fat correlated independently with higher blood folate, specific microbial shifts, and elevated metabolic products of polyphenols (urolithin A and tyrosol), suggesting the diet's effects worked through measurable biochemical pathways.

Why it matters for you

If you track lipid panels and inflammatory markers, this work suggests adding polyphenol-rich foods—especially green tea and plant-based protein sources—may shift these metrics more than general calorie reduction alone. The connection between better insulin sensitivity and less brain atrophy is particularly relevant if you monitor fasting glucose, HOMA-IR, or HbA1c; metabolic control appears to have structural brain consequences over an 18-month window.

Liver fat is increasingly recognized as a metabolic linchpin affecting insulin sensitivity, lipid profiles, and systemic inflammation. If you've had an ultrasound or DEXA showing hepatic steatosis, or elevated ALT/AST, this trial directly addresses a common finding in people optimizing health markers. The 31.5% prevalence of fatty liver in the green group (down from 62%) is clinically meaningful—moving from disease to normal range.

The practical implementation is straightforward: the protocol added ~3–4 cups of green tea daily and 100g of frozen Mankai in a smoothie, plus walnuts and reduced red/processed meat. These aren't exotic interventions, though Mankai availability varies by region. The study included structured physical activity guidance and gym access, so the diet effect occurred alongside exercise—not in isolation.

Caveats

• Observational associations, not proof of mechanism: While polyphenol metabolites correlated with better outcomes, we can't conclude they caused the improvements; multiple dietary changes occurred together.
• Predominantly male, urban workforce: 88% men in a workplace with monitored dining. Results may not generalize to women, different age groups, or less controlled eating environments.
• Modest absolute changes in brain imaging: Hippocampal and ventricle differences were small in absolute terms over 18 months, though directional and consistent.
• No long-term follow-up data: 18 months is reasonable but doesn't show whether benefits persist after stopping, or compound over years.
• Mankai availability and cost: This is a niche cultivated crop; accessibility and expense may limit real-world adoption in many regions.